Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Rathkopf
    Rathkopf
  2. Scher
    Scher
  3. Morris
    Morris
  4. Abida
    Abida
  5. Autio
    Autio
  6. Gopalan
    Gopalan
  7. Nandakumar
    Nandakumar
  8. Solit
    Solit
  9. Benfante
    Benfante
  10. Birsoy
    Birsoy

Groups

  1. Department of Medicine (14)
  2. Genitourinary Oncology Service (14)
  3. Solid Tumor Oncology Division (14)
  4. Epidemiology and Biostatistics (2)
  5. GDMT, Medicine (2)
  6. GSK Faculty (2)
  7. Gynecologic Medicine Service (2)
  8. Gynecology Disease Management Team (2)
  9. Human Oncology and Pathogenesis Program (2)
  10. Breast Medicine Service (1)
Search Within
  1. "European Urology"
  2. "Dana Rathkopf"
Formats
  1. Journal Article (12)
  2. Editorial (1)
  3. Review (1)
Groups
  1. Department of Medicine (14)
  2. Genitourinary Oncology Service (14)
  3. Solid Tumor Oncology Division (14)
  4. Epidemiology and Biostatistics (2)
  5. GDMT, Medicine (2)
  6. GSK Faculty (2)

More Groups

People
  1. Dana Rathkopf (14)
  2. Howard Scher (10)
  3. Michael Morris (5)
  4. Anuradha Gopalan (2)
  5. David Solit (2)
  6. Karen Autio (2)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2020 (1)
  4. 2017 (3)
  5. 2016 (3)
  6. 2015 (2)

More Years

Publications
  1. European Urology (14)

Results (14)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of patients with advanced prostate cancer. Part I: Intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of hormonal treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022
    Journal Article

    Gillessen, S.; Bossi, A.; Davis, I. D.; de Bono, J.; Fizazi, K.; James, N. D.; Mottet, N.; Shore, N.; Small, E.; Smith, M.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Gene-based confirmatory germline testing following tumor-only sequencing of prostate cancer
    Journal Article

    Truong, H.; Breen, K.; Nandakumar, S.; Sjoberg, D. D.; Kemel, Y.; Mehta, N.; Lenis, A. T.; Reisz, P. A.; Carruthers, J.; Benfante, N.; more...
    European Urology (2023)

    Fulltext@MSK | Save
  • Management of patients with advanced prostate cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Review

    Gillessen, S.; Armstrong, A.; Attard, G.; Beer, T. M.; Beltran, H.; Bjartell, A.; Bossi, A.; Briganti, A.; Bristow, R. G.; Bulbul, M.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • What experts think about prostate cancer management during the COVID-19 pandemic: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Editorial

    Turco, F.; Armstrong, A.; Attard, G.; Beer, T. M.; Beltran, H.; Bjartell, A.; Bossi, A.; Briganti, A.; Bristow, R. G.; Bulbul, M.; more...
    European Urology (2022)

    Fulltext@MSK | Save
  • Pan-cancer analysis of CDK12 alterations identifies a subset of prostate cancers with distinct genomic and clinical characteristics
    Journal Article

    Nguyen, B.; Mota, J. M.; Nandakumar, S.; Stopsack, K. H.; Weg, E.; Rathkopf, D.; Morris, M. J.; Scher, H. I.; Kantoff, P. W.; Gopalan, A.; more...
    European Urology (2020)

    Fulltext@MSK | Save
  • Clinical outcomes from androgen signaling-directed therapy after treatment with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: Post hoc analysis of COU-AA-302
    Journal Article

    Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; De Bono, J. S.; Small, E. J.; Shore, N. D.; Fizazi, K.; Kheoh, T.; Li, J.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Subsequent chemotherapy and treatment patterns after abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Post hoc analysis of COU-AA-302
    Journal Article

    de Bono, J. S.; Smith, M. R.; Saad, F.; Rathkopf, D. E.; Mulders, P. F. A.; Small, E. J.; Shore, N. D.; Fizazi, K.; De Porre, P.; Kheoh, T.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Enzalutamide in men with chemotherapy-naïve metastatic castration-resistant prostate cancer: Extended analysis of the phase 3 PREVAIL study
    Journal Article

    Beer, T. M.; Armstrong, A. J.; Rathkopf, D.; Loriot, Y.; Sternberg, C. N.; Higano, C. S.; Iversen, P.; Evans, C. P.; Kim, C. S.; Kimura, G.; more...
    European Urology (2017)

    Fulltext@MSK | Save
  • Phase 2 study of the safety and antitumor activity of apalutamide (ARN-509), a potent androgen receptor antagonist, in the high-risk nonmetastatic castration-resistant prostate cancer cohort
    Journal Article

    Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W. R.; Shore, N. D.; Liu, G.; Alumkal, J. J.; Higano, C. S.; Chow Maneval, E.; Bandekar, R.; more...
    European Urology (2016)

    Fulltext@MSK | Save
  • Low incidence of corticosteroid-associated adverse events on long-term exposure to low-dose prednisone given with abiraterone acetate to patients with metastatic castration-resistant prostate cancer
    Journal Article

    Fizazi, K.; Chi, K. N.; de Bono, J. S.; Gomella, L. G.; Miller, K.; Rathkopf, D. E.; Ryan, C. J.; Scher, H. I.; Shore, N. D.; De Porre, P.; more...
    European Urology (2016)

    Fulltext@MSK | Save